How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/reduction-of-risk-of-upper-gastrointestinal-bleeding.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Reduction of risk of upper gastrointestinal bleeding — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reduction of risk of upper gastrointestinal bleeding (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Reduction of risk of upper gastrointestinal bleeding, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Prilosec	omeprazole	AstraZeneca (originally Astra AB)	Proton pump inhibitor (PPI)	ATP-binding cassette sub-family G member 2, Cytochrome P450 1A2, Cytochrome P450 2C19	1989-09-14
Golytely	Sodium Bicarbonate	Abbott	sodium bicarbonate		1981-01-01
Omeprazol	Omeprazol	RenJi Hospital		ATP-binding cassette sub-family G member 2, Cytochrome P450 1A2, Cytochrome P450 2C19

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Abbott · 1 drug in Reduction of risk of upper gastrointestinal bleeding
AstraZeneca (originally Astra AB) · 1 drug in Reduction of risk of upper gastrointestinal bleeding
RenJi Hospital · 1 drug in Reduction of risk of upper gastrointestinal bleeding

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Reduction of risk of upper gastrointestinal bleeding:

Cite this brief

Drug Landscape (2026). Reduction of risk of upper gastrointestinal bleeding — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/reduction-of-risk-of-upper-gastrointestinal-bleeding. Accessed 2026-06-10.

Reduction of risk of upper gastrointestinal bleeding full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing